Standard vs High Dose of Unfractionated Heparin in the Incidence of Radial Artery Occlusion (DEFINITION) Trial.
NCT04561648 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 1988
Last updated 2024-02-20
Summary
Double blind single center clinical trial to compare the incidence of radial artery occlusion (RAO) using standard doses of Unfractionated Heparin (UFH) vs. high doses of UFH.
Conditions
- Radial Artery Occlusion
Interventions
- DRUG
-
Unfractionated Heparin
Before removing the introducer sheath, the 2nd operator will pass the missing UFH dose to the first operator to reach 100 IU per kg of body weight in a 10 ml syringe mixed with 0.9% saline solution. The blinded first operator will administer this without knowing if it is saline or the supplemental dose of unfractionated heparin.
Sponsors & Collaborators
-
Instituto Nacional de Cardiologia Ignacio Chavez
lead OTHER
Principal Investigators
-
Guering Eid Lidt, M.D. · Instituto Nacional de Cardiología Ignacio Chávez
-
Julio I Farjat Pasos, M.D. · Instituto Nacional de Cardiología Ignacio Chávez
-
Carlos Aguila Bravo, M.D. · Instituto Nacional de Cardiología Ignacio Chávez
-
Monserrat Villalobos Pedroza, M.D. · Instituto Nacional de Cardiología Ignacio Chávez
Study Design
- Allocation
- RANDOMIZED
- Purpose
- PREVENTION
- Masking
- DOUBLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2020-08-01
- Primary Completion
- 2025-12-01
- Completion
- 2026-03-01
Countries
- Mexico
Study Locations
More Related Trials
-
Evaluation of the Pharmacodynamics of a Heparin With Its Biological Comparator, Subcutaneous Administration
NCT05788913 ·Status: UNKNOWN ·Phase: PHASE1
-
Evaluation of the Amiens University Hospital Neuroradiology Anticoagulation Protocol
NCT02848612 ·Status: COMPLETED
-
Safe and Fast Radial Hemostasis Using Synergistic Strategies: SAFE & FAST Trial
NCT06549842 ·Status: COMPLETED ·Phase: NA
-
Etude (Study) Phase I Enox - UnFractionated Heparin (UFH)
NCT00622115 ·Status: COMPLETED ·Phase: PHASE1
-
Comparision Between Activated Partial Thromboplastin Time Versus Anti-Xa Activity in Heparin Monitoring
NCT03426982 ·Status: UNKNOWN ·Phase: PHASE4
-
Early Versus Late Resumption of Anticoagulation in Patients With Both High Thrombosis Risk and Major HEmoRrhage
NCT02091479 ·Status: TERMINATED ·Phase: PHASE3
-
Evaluation of the Pharmacodynamics of a Heparin With Its Biological Comparator, Intravenous Administration
NCT05788900 ·Status: UNKNOWN ·Phase: PHASE1
-
Study With Heparin Sodium in Subcutaneous Administration
NCT03113084 ·Status: SUSPENDED ·Phase: PHASE1
-
Evaluation of Anti-Xa Levels in Surgery Patients Receiving Fixed Dose Heparin
NCT02970032 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Predictive Factors for Response to New Oral Anticoagulants in the Treatment of Non-valvular Atrial Fibrillation..
NCT04297150 ·Status: UNKNOWN
-
A Study Comparing the Local Tolerability of Two Subcutaneous Heparins in Healthy Volunteers.
NCT03841396 ·Status: COMPLETED ·Phase: PHASE4
-
Prospective Study on the Role of Intravenous Unfractionated Heparin Following Digital Replantation and Revascularization
NCT04725201 ·Status: RECRUITING ·Phase: PHASE4
-
Evaluation of Anti-Xa Levels in Surgery Patients Receiving Weight-based Heparin
NCT03516656 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Optimized Heparin Regimen in Vascular Surgery
NCT02477072 ·Status: COMPLETED ·Phase: NA
-
A Comparison of Certoparin and Unfractionated Heparin in the Prevention of Thromboembolic Events in Acutely Ill Medical Patients
NCT00451412 ·Status: COMPLETED ·Phase: PHASE3
-
Medication Use Evaluation (MUE) for Continuous Heparin Infusions in Hospitalized Patients
NCT06096064 ·Status: COMPLETED
-
Effect of Intravenous Continuous Infusion Heparin on Rates of Venous Thromboembolism in High-Risk, Critically Ill Patients
NCT02707263 ·Status: WITHDRAWN ·Phase: NA
-
Innohep® in Elderly Patients With Impaired Renal Function Treated for Acute Deep Vein Thrombosis
NCT00277394 ·Status: COMPLETED ·Phase: PHASE4
-
Study to Assess the Pharmacodynamic Effects of Unfractionated Heparin (UFH) in Healthy Volunteers With and Without Bendavia
NCT01513200 ·Status: COMPLETED ·Phase: PHASE1
-
Treatment of Upper Extremity Deep-Vein Thrombosis
NCT00245856 ·Status: COMPLETED ·Phase: PHASE4
-
Catheter Directed Interventions in Pulmonary Embolism
NCT03595085 ·Status: UNKNOWN ·Phase: NA
-
Low Dose Heparin Factorial Trial
NCT05591872 ·Status: UNKNOWN ·Phase: PHASE3
-
The Effect of Exercise on Pharmacodynamics and Pharmacokinetics of a Single Dose of Unfractionated Heparin
NCT06174961 ·Status: COMPLETED ·Phase: PHASE4
-
Comparison of Low-Molecular-Weight Heparin (LMWH) and Unfractionated Heparin (UFH) in Combination With Thrombolytic Treatment of Acute Massive Pulmonary Thromboembolism
NCT01956955 ·Status: UNKNOWN ·Phase: PHASE4
-
Evaluation of the Interference of Antithrombotic Agents With Laboratory Monitoring of Heparin Therapy
NCT02839434 ·Status: TERMINATED